List view / Grid view

News

Janssen collaborates to further evaluate SIRTURO® (bedaquiline) in new multidrug-resistant tuberculosis treatment regimens

6 November 2014 | By

Janssen Research & Development, LLC (Janssen) today announced a collaboration with the International Union Against Tuberculosis and Lung Disease (The Union) to include SIRTURO® (bedaquiline) in the STREAM Study. The STREAM study is an ongoing, multi-centre international randomized controlled trial to evaluate a standardized treatment regimen of anti-tuberculosis drugs for patients…

Half of people with hepatitis C unaware

5 November 2014 | By Public Health England

Around half of the people living with hepatitis C infections don’t know it, according to a new publication out today from Public Health England (PHE), “Shooting Up: Infections among people who inject drugs in the United Kingdom 2013”...

TxCell reports revenues for the third quarter of 2014

5 November 2014 | By TxCell

TxCell (FR0010127662 - TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues(1) as of September 30, 2014...

BerGenBio announces first patient dosed in BGB324 AML trial

5 November 2014 | By BerGenBio AS

BerGenBio AS announces that the first patient has been dosed in its multi-centre Phase 1b trial (BGBC003) of BGB324, a selective inhibitor of Axl, in patients with acute myeloid leukaemia (AML) at Haukeland University Hospital in Bergen, Norway...

Lonza Group Ltd. and CAMO Software AS have entered into an agreement to deliver a PAT software solution to the Lonza Visp site

5 November 2014 | By

CAMO Software, leaders in multivariate data analysis software, and Lonza Group, a leading supplier to the pharma, biotech and specialty ingredients markets, have entered into an agreement where CAMO Software will deliver a PAT software solution for collecting, handling, storing, monitoring and modeling of PAT data. The solution will complement…

Santen establishes subsidiary in United Kingdom

4 November 2014 | By Santen Pharmaceutical Co

Santen Pharmaceutical Co., Ltd. announced the establishment of a wholly owned subsidiary in The United Kingdom (UK) to serve customers and patients in the UK and Ireland...